Clinical trials
Completed Dyslipidemias trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 7 |
| 2007 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 8 |
| Amgen | 3 |
| AstraZeneca | 3 |
| 89bio, Inc. | 2 |
| NewAmsterdam Pharma | 2 |
| Abbott | 1 |
| Boehringer Ingelheim | 1 |
| Genentech, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 24 |
| Glucose Metabolism Disorders | 8 |
| Diabetes Mellitus | 7 |
| Diabetes Mellitus, Type 2 | 7 |
| Hypercholesterolemia | 7 |
| Hyperlipidemias | 3 |
| Hypertriglyceridemia | 3 |
| Lipid Metabolism Disorders | 3 |
| Cardiovascular Diseases | 2 |
| Coronary Disease | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.